Davis Polk & Wardwell is advising Gilead Sciences, Inc. on the transaction, and Cravath, Swaine & Moore is advising CymaBay Therapeutics, Inc. Gilead Sciences, Inc. (Gilead)...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Tenaya Therapeutics on the transaction, and Davis Polk & Wardwell advised the underwriters. Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advised Immatics N.V. on the offering, and Covington & Burling advised the underwriters. Immatics N.V. (Nasdaq: IMTX) announced its $201 million SEC-registered offering...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Alector in the offering, and Davis Polk & Wardwell represented the sole book-running manager and underwriter, Cantor Fitzgerald & Co....
You must be a Standard 1 Year member to access this content.
Cooley advised Olema Pharmaceuticals, Inc. on the offering, and Davis Polk & Wardwell advised TD Cowen, as sales agent. Olema Pharmaceuticals ((“Olema”, Nasdaq: OLMA) announced its $150...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advised GSK on the transaction. GSK plc (LSE/NYSE: GSK) and Hansoh Pharma (HKEX: 03692) announced that they have entered into an exclusive license...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advised the representatives of the several initial purchasers on the offering. Merit Medical Systems, Inc. (Nasdaq: MMSI) (Merit) announced its $747.5 million of its...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Integral Ad Science Corp. and entities affiliated with Vista on the offering, and Davis Polk & Wardwell advised the underwriter. Integral Ad...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell is advising Smith+Nephew on the transaction. Smith+Nephew (NYSE:SNN) announced it has entered into a definitive agreement of CartiHeal. Under the terms of the...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Bristol Myers Squibb Company on the offering, while Davis Polk & Wardwell advised the joint book-running managers and representatives of the underwriters....
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advised the sales agent on the offering. NeuroPace (Nasdaq:NPCE) announced a $50 million SEC-registered at-the-market offering of its common stock. Based in Mountain...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advised GSK on the deal. GSK plc (LSE/NYSE: GSK) and Hansoh Pharma (HKEX: 03692) announced that they have entered into an exclusive license...
You must be a Standard 1 Year member to access this content.
